CHB
Global X China Biotech Innovation ETF
Delisted
CHB was delisted on the 16th of February, 2024.
3 hedge funds and large institutions have $373K invested in Global X China Biotech Innovation ETF in 2023 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
3
Holders Change
–
Holders Change %
0%
% of All Funds
0.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
2
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Jane Street
New York
|
+$84.7K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$680 |
Top Sellers
| 1 |
UBS Group
Zurich,
Switzerland
|
-$9.99K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Citadel Advisors
Miami,
Florida
| $197K | +$680 | +84 | +0.3% |
|
|
2
Jane Street
New York
| $176K | +$84.7K | +10,459 | +93% |
|
|
3
UBS Group
Zurich,
Switzerland
| $186 | -$9.99K | -1,235 | -98% |
|